<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05067907</url>
  </required_header>
  <id_info>
    <org_study_id>FISIO-UTI-COVID</org_study_id>
    <nct_id>NCT05067907</nct_id>
  </id_info>
  <brief_title>Efficacy of Respiratory Physiotherapy on Severe ICU-admitted COVID-19 Patients.</brief_title>
  <official_title>Efficacy of Respiratory Physiotherapy on Severe ICU-admitted COVID-19 Patients: a Multicentric, National, Observational, Retrospective Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      COVID-19 is an infectious disease caused by SARS-CoV2 virus. COVID-19 patients can develop a&#xD;
      severe disease that can lead to hypoxic respiratory failure and acute respiratory distress&#xD;
      syndrome (ARDS). Severe patients can require access to intensive care unit (ICU). Early&#xD;
      rehabilitation is known to be effective in critically ill patients and in ARDS.&#xD;
&#xD;
      Early rehabilitation is known to be effective in critically ill subjects. The role of&#xD;
      physiotherapy in severe COVID-19 patients is still unclear and few guidelines have been&#xD;
      proposed so far. Aim of this study is to assess efficacy of early rehabilitation for severe&#xD;
      ICU-admitted COVID-19 patients as compared to a group that did not received physiotherapy&#xD;
      treatment in ICU.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      COVID-19 is an infectious disease caused by severe acute respiratory syndrome coronavirus 2&#xD;
      (SARS-CoV-2), which emerged in China in December 2019 and in Italy in February 2020. A large&#xD;
      proportion of infected people have mild clinical manifestations, whereas &gt;10% develop a&#xD;
      severe disease, which could evolve into acute hypoxemic respiratory failure (AHRF) and acute&#xD;
      respiratory distress syndrome (ARDS) requiring intensive care unit (ICU) admission. A high&#xD;
      proportion of ICU patients need invasive mechanical ventilation (IMV) and about 50% of the&#xD;
      ICU-admitted patients die. The median age of ICU COVID-19 patients was &lt;65 years and the&#xD;
      mortality in patients aged &lt;63 years ranges from 15 to 20%.&#xD;
&#xD;
      Early rehabilitation is safe and effective in critically ill patients and, in patients with&#xD;
      ARDS, it helps to reduce the functional impairment due to the prolonged stay in ICU.&#xD;
      Preliminary data suggest the implementation of early and active mobilization programs, as&#xD;
      well as airway clearance, for patients with severe forms of COVID-19. To date, the role of&#xD;
      respiratory physiotherapy in severe COVID-19 patients is still unclear.&#xD;
&#xD;
      Aim of this study is to assess efficacy of early rehabilitation for severe ICU-admitted&#xD;
      COVID-19 patients as compared to a group that did not recevied physiotherapy treatment in&#xD;
      ICU. Physiotherapy efficacy is evaluated in terms of ventilator free days (VFD) during the&#xD;
      first 30 days after neuromuscular blockade stop.&#xD;
&#xD;
      Moreover, duration of ICU stay and patient functional status at ICU discharge will be&#xD;
      evaluated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ventilator-free days (VFD) and alive at day 28</measure>
    <time_frame>Up to 28 days after neuromuscular blokade stop</time_frame>
    <description>To determine if early physiotherapy, as compared to no physiotherapy treatment, increases the number of ventilator-free days (VFD) and alive at day 28 in severe COVID-19 ICU-admitted patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU stay duration</measure>
    <time_frame>From ICU admission to ICU discharge; up to 60 days.</time_frame>
    <description>Mean days of ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PaO2/FiO2</measure>
    <time_frame>At ICU discharge; up to 60 days</time_frame>
    <description>Mean measure of PaO2/FiO2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU survival rate</measure>
    <time_frame>From ICU admission until date of death from any cause, during ICU stay; up to 100 days.</time_frame>
    <description>Number of patients that survived ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital survival rate</measure>
    <time_frame>From ICU admission until date of death from any cause, during hospitalization</time_frame>
    <description>Number of patients that survived hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>90 days survival rate</measure>
    <time_frame>From ICU admission until date of death from any cause, assessed up to 90 days after neuromuscular blokade removal</time_frame>
    <description>Number of patients that survived during 90 days after neuromuscular blokade stop</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">340</enrollment>
  <condition>COVID-19 Acute Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>COVID-19 ICU-admitted patients that did not received physiotherapy interventions during ICU stay.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physiotherapy</arm_group_label>
    <description>COVID-19 ICU-admitted patients that received physiotherapy interventions during ICU stay.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Early physiotherapy</intervention_name>
    <description>Respiratory physiotherapy included:&#xD;
early and functional mobilization: passive and active mobilization, muscle strengthening, improving independence in activities of daily living (ADL), sitting out of bed, standing, walking;&#xD;
patient positioning to achieve better ventilation/perfusion ratio and gas exchange;&#xD;
airway clearance;&#xD;
aerosol administration;&#xD;
invasive mechanical ventilation weaning;&#xD;
use of non-invasive mechanical ventilation (NIMV) and continuous positive airway pressure (CPAP);&#xD;
tracheostomy management and weaning;&#xD;
swallowing assessment;&#xD;
management of oxygen delivery;&#xD;
lung expansion;&#xD;
patient assessment and functional scale administration.</description>
    <arm_group_label>Physiotherapy</arm_group_label>
    <other_name>respiratory physiotherapy</other_name>
    <other_name>early rehabilitation</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Investigators will study patients accessing acute hospital ICU with hypoxemic acute&#xD;
        respiratory failure (hARF) due to laboratory confirmed COVID-19 pneumonia form March 1st to&#xD;
        May 30th.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Having laboratory confirmed COVID-19 pneumonia&#xD;
&#xD;
          -  Developed hypoxemic acute respiratory failure (hARF) requiring access to ICU&#xD;
&#xD;
          -  Treated by physiotherapists during the ICU stay&#xD;
&#xD;
          -  Stopped the neuromuscular blokade treatment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previuos cognitive deficit (Mini menatal state examination &lt;20)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emilia Privitera, MSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emilia Privitera, MSC</last_name>
    <phone>00393385670909</phone>
    <email>emilia.privitera@policlinico.mi.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Martina Santambrogio, PhD</last_name>
    <phone>00393393838807</phone>
    <email>msantambrogio@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>ASST Grande Ospedale Metropolitano Niguarda</name>
      <address>
        <city>Milano</city>
        <state>Milan</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Fumagalli, Prof</last_name>
    </contact>
    <contact_backup>
      <last_name>Maurizio Sommariva, PT</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ospedale Maggiore di Crema</name>
      <address>
        <city>Crema</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guido Merli, Prof.</last_name>
    </contact>
    <contact_backup>
      <last_name>Marzia Danzi, PT</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ospedale San Martino</name>
      <address>
        <city>Genova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paolo Pelosi, Prof</last_name>
    </contact>
    <contact_backup>
      <last_name>Salvatore Caiffa, PT</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milano</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emilia Privitera, MSC</last_name>
      <phone>0039 3385670909</phone>
      <email>emilia.privitera@policlinico.mi.it</email>
    </contact>
    <contact_backup>
      <last_name>Martina Santambrogio, PhD</last_name>
      <phone>0039 3393838807</phone>
      <email>msantambrogio@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>APSS Provincia Autonoma di Trento Ospedale Santa Chiara</name>
      <address>
        <city>Trento</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniele Penzo, Prof.</last_name>
    </contact>
    <contact_backup>
      <last_name>Valentina Turrin, PT</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.</citation>
    <PMID>31986264</PMID>
  </results_reference>
  <results_reference>
    <citation>Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, Ross A, Anderson L, Baker S, Sanchez M, Penley L, Howard A, Dixon L, Leach S, Small R, Hite RD, Haponik E. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med. 2008 Aug;36(8):2238-43. doi: 10.1097/CCM.0b013e318180b90e.</citation>
    <PMID>18596631</PMID>
  </results_reference>
  <results_reference>
    <citation>Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall JB, Kress JP. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009 May 30;373(9678):1874-82. doi: 10.1016/S0140-6736(09)60658-9. Epub 2009 May 14.</citation>
    <PMID>19446324</PMID>
  </results_reference>
  <results_reference>
    <citation>Kim RY, Murphy TE, Doyle M, Pulaski C, Singh M, Tsang S, Wicker D, Pisani MA, Connors GR, Ferrante LE. Factors Associated With Discharge Home Among Medical ICU Patients in an Early Mobilization Program. Crit Care Explor. 2019 Nov 11;1(11):e0060. doi: 10.1097/CCE.0000000000000060. eCollection 2019 Nov.</citation>
    <PMID>32166241</PMID>
  </results_reference>
  <results_reference>
    <citation>Lazzeri M, Lanza A, Bellini R, Bellofiore A, Cecchetto S, Colombo A, D'Abrosca F, Del Monaco C, Gaudiello G, Paneroni M, Privitera E, Retucci M, Rossi V, Santambrogio M, Sommariva M, Frigerio P. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR). Monaldi Arch Chest Dis. 2020 Mar 26;90(1). doi: 10.4081/monaldi.2020.1285.</citation>
    <PMID>32236089</PMID>
  </results_reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>August 30, 2021</study_first_submitted>
  <study_first_submitted_qc>October 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2021</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

